Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04535271
Title Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Leiomyosarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sarcoma Oncology Research Center, LLC
Indications

leiomyosarcoma

Therapies

Dacarbazine + Gemcitabine + Trabectedin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.